Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Higher DHEA-S levels in hirsute females affect hair growth phases.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Men with enlarged prostates often have more severe baldness.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Androgenetic alopecia is more common in men, linked to genetics and androgen levels, but routine pelvic ultrasound isn't recommended.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The HSD3B1 variant increases hair loss risk in overweight women with PCOS.

Severe hair loss in Chinese men is linked to high blood pressure, while in women, it's linked to larger waist size and cholesterol issues.

Higher serum androgens contribute to male pattern baldness.

People with androgenetic alopecia are more likely to have metabolic syndrome.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Newborn acne may be linked to family history of high male hormone levels.

Male hormones worsen kidney transplant damage, but blocking them helps.

Most women with hirsutism in the UAE have polycystic ovary syndrome (PCOS).

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

Skin issues like hirsutism, acne, and acanthosis nigricans are common in PCOS and linked to hormone and metabolic changes.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

A woman's ovarian fibroma caused high testosterone levels, which normalized after surgery.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

A man developed hair loss from testosterone treatment but improved with additional medication.

Androgenetic alopecia is more common in men, often linked to genetics and hormones.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.